Berkshire Pershing Square? Here’s My Ten-Year Pick Now
Berkshire Hathaway ramps up buybacks and sits on a large cash cushion, while Pershing Square slips 16% year-to-date a...
Maximizing credit card point value can lead to incredible benefits. Discover effective strategies to boost your rewards potential.
25,565 articlesBerkshire Hathaway ramps up buybacks and sits on a large cash cushion, while Pershing Square slips 16% year-to-date a...
When geopolitics collide with global manufacturing, one top EV maker shows how to turn risk into growth. This story d...
Contrarian investors are eyeing simply good foods stock as a potential turnaround play. This article breaks down the ...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
Nebius stock has drawn attention with recent deals and rising prices. This guide explores whether could buying Nebius...
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
A major shift in early trading set the tone for Accenture's latest results. This article explains why accenture stock...
Palantir has slipped significantly from its all-time high, prompting questions about a buy-the-dip opportunity. This ...
A biotech insider sale can spark questions about company momentum. This article digs into the Stoke Therapeutics CMO ...
When a large manager trims a position, questions follow. This article breaks down Hilton Capital’s $25 million GPIX s...
Berkshire Hathaway disclosed a new stake in Macy’s in its Q1 2026 13F, a small starter position that contrasts with p...
Dive into a practical guide on Revolution Medicines earnings. Learn to parse transcripts, spot the signals that matte...